AVX001 Gel
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for AVX001 Gel, covering 2022-01-27 to 2022-01-27. Get the full timeline:
Most recent: Clinical Trial Update: Phase I/IIa Trial to Evaluate AVX001 Gel in Doses of 1% or 3% Compared With Vehicle Over Four Weeks of Field-directed Treatment Period in Adult Subjects With AK [Phase 1, Phase 2]